NCT05082766

Improvement in the Appearance of Periorbital Wrinkles

Improvement in the Appearance of Periorbital Wrinkles With DefenAge 8-in-1 BioSerum Supplemented With Enhanced Concentration of Defensins

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
• Sex: All
• Age: 31 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this study is to evaluate the efficacy of DefenAge 8-in-1 BioSerum supplemented with the enhanced concentration of defensins (enhanced 8-in-1 BioSerum) in the improvement of periorbital wrinkles.

Detailed description

Enrolled subjects will all receive enhanced DefenAge 8-in-1 BioSerum to be applied on the face including periorbital area. Subjects satisfying all inclusion and exclusion criteria will be enrolled in this trial. Prior to receiving any study treatment, mandatory photography using Canfield Vectra 3D and VISIA. Patients will return for follow-up assessments at Day 30, 60, and 90.

Conditions

• Periorbital Wrinkles

Interventions

Type	Name	Description
DRUG	enhanced DefenAge 8-in-1 BioSerum	DefenAge is a topical skincare brand containing a composition of biologically active natural molecules, named defensins, that repair skin damage associated with aging.

Timeline

• Start date: 2021-10-11
• Primary completion: 2022-10-11
• Completion: 2022-12-01
• First posted: 2021-10-19
• Last updated: 2021-10-28

Locations

1 site across 1 country: United States